Variability in hemoglobin A1c predicts all-cause mortality in patients with type 2 diabetes

Journal of Diabetes and its Complications

Volumn 26, Issue 4, 2012, Pages 296-300

  Ma, Wen Ya ^a,b   Li, Hung Yuan ^c   Pei, Dee ^a,b   Hsia, Te Lin ^a,b   Lu, Kuo Cheng ^a,b   Tsai, Li Yu ^a   Wei, Jung Nan ^d   Su, Ching Chieh ^a,b  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

A1C variability; Glucose fluctuations; Hemoglobin A1c; Mortality; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETIC PATIENT; FEMALE; FOLLOW UP; GENDER AND SEX; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SMOKING CESSATION; SURVIVAL PREDICTION; SYSTOLIC BLOOD PRESSURE;

AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84863783577     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.03.028     Document Type: Article

References (32)

1. Asche, C., Lafleur, J., & Conner, C. (2011). A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clinical Therapeutics, 33(1), 74-109.
2. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865), 813-820.
3. Ceriello,A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa,R., et al. (2008). Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes, 57(5), 1349-1354.
4. Chen, H. -S., Jap, T. -S., Chen, R. -L., & Lin, H. -D. (2004). A prospective study of glycemic control during holiday time in type 2 diabetic patients. Diabetes Care, 27(2), 326-330. (Pubitemid 38174052)
5. Chen, H. S., Wu, T. E., Jap, T. S., Chen, R. L., & Lin, H. D. (2008). Effects of health education on glycemic control during holiday time in patients with type 2 diabetes mellitus. American Journal of Managed Care, 14(1), 45-51.
6. DCCT. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine, 329(14), 977-986.
7. DCCT. (1995). The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes, 44(8), 968-983.
8. Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., et al. (2009). Glucose control and vascular complications in veterans with type 2 diabetes. New England Journal of Medicine, 360(2), 129-139.
9. Gebregziabher, M., Egede, L. E., Lynch, C. P., Echols, C., & Zhao, Y. (2010). Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach. American Journal of Epidemiology, 171(10), 1090-1098.
10. Gerstein, H. C., Miller, M. E., Byington, R. P., Goff, D. C., Jr., Bigger, J. T., Buse, J. B., et al. (2008). Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine, 358(24), 2545-2559. (Pubitemid 351831356)
11. Gerstein, H. C., Miller, M. E., Genuth, S., Ismail-Beigi, F., Buse, J. B., Goff, D. C., Jr., et al. (2011). Long-term effects of intensive glucose lowering on cardiovascular outcomes. New England Journal of Medicine, 364(9), 818-828.
12. Gikas, A., Sotiropoulos, A., Pastromas, V., Papazafiropoulou, A., Apostolou, O., & Pappas, S. (2009). Seasonal variation in fasting glucose and HbA1c in patients with type 2 diabetes. Primary Care Diabetes, 3(2), 111-114.
13. Hamer, M., Stamatakis, E., Kivimaki, M., Pascal Kengne, A., & Batty, G. D. (2011). Psychological distress, glycated hemoglobin, and mortality in adults with and without diabetes. Psychosomatic Medicine, 72(9), 882-886.
14. Jones, S. C., Saunders, H. J., Qi, W., & Pollock, C. A. (1999). Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia, 42(9), 1113-1119. (Pubitemid 29408810)
15. Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2008). A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care, 31(11), 2198-2202.
16. Koskinen, P., Erkkola, R., Viikari, J., Mattila, K., & Irjala, K. (1992). Blood glycated haemoglobin, serum fructosamine, serum glycated albumin and serum glycated total protein as measures of glycaemia in diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation, 52(8), 863-869. (Pubitemid 23000807)
17. Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., & Roth, D. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Annals of Internal Medicine, 130(6), 461-470. (Pubitemid 29135798)
18. Levey, A. S., Greene, T., Kusek, J., & Beck, G. (2000). A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. Journal of the American Society of Nephrology, 11, 155A.
19. Li, H. -Y., Jiang, Y. -D., Chang, T. -J., Wei, J. -N., Lin, M. -S., Lin, C. -H., et al. (2011). Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes. Diabetes, 60(3), 993-999.
20. Maciejewski, M. L., Dowd, B., Call, K. T., & Feldman, R. (2001). Comparing mortality and time until death for medicare HMO and FFS beneficiaries. Health Services Research, 35(6), 1245-1265. (Pubitemid 32163979)
21. Monnier, L., Colette, C., & Owens, D. R. (2008). Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? Journal of Diabetes Science and Technology, 2(6), 1094-1100.
22. Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J. P., et al. (2006). Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. Journal of the American Medical Association, 295(14), 1681-1687.
23. Muggeo, M., Zoppini, G., Bonora, E., Brun, E., Bonadonna, R. C., Moghetti, P., et al. (2000). Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care, 23(1), 45-50. (Pubitemid 30022893)
24. Newcomer, J. W. (2007). Antipsychotic medications: metabolic and cardiovascular risk. Journal of Clinical Psychiatry, 68(Suppl. 4), 8-13.
25. Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., et al. (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358(24), 2560-2572. (Pubitemid 351831357)
26. Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003). Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes, 52(11), 2795-2804. (Pubitemid 37339710)
27. Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A., et al. (2009). Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care, 32(1), 187-192.
28. Suhonen, L., Stenman, U., Koivisto, V., & Teramo, K. (1989). Correlation of HbA1C, glycated serum proteins and albumin, and fructosamine with the 24-h glucose profile of insulin-dependent pregnant diabetics. Clinical Chemistry, 35(6), 922-925. (Pubitemid 19161257)
29. Tuomilehto, J. (1999). Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet, 354(9179), 617-621.
30. Turner, R. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, 352(9131), 837-853.
31. Waden, J., Forsblom, C., Thorn, L. M., Gordin, D., Saraheimo, M., & Groop, P. H. (2009). A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes, 58(11), 2649-2655.
32. Welch, H. G., Sharp, S. M., Gottlieb, D. J., Skinner, J. S., & Wennberg, J. E. (2011). Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. Journal of the American Medical Association, 305(11), 1113-1118.